Physician profile
Antonia Teruel Castellon
NPI 1477829927
$4,513.98
in general payments reported to CMS, 2019-2025
14 companies · $520 in 2025
The $520 reported for 2025 was more than what 96% of Orofacial Pain providers received nationally (typical 2025 total: $95.41).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $152 · 2021: $718 · 2022: $928 · 2023: $766 · 2024: $594 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,881.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,914.00 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Allergan, INC. | $644.60 | 2019-2022 | |
| Amgen INC. | $425.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $381.55 | 2019-2021 | |
| Lundbeck LLC | $236.80 | 2022-2025 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $189.07 | 2021 | |
| Pfizer INC. | $167.56 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $165.62 | 2019-2025 | Ajovy |
| Biohaven Pharmaceutical Holding Company Ltd. | $128.05 | 2022 | |
| Promius Pharma LLC | $124.99 | 2019 | |
| Impel Pharmaceuticals INC. | $67.47 | 2023 | Trudhesa |
| Lilly USA, LLC | $45.40 | 2019-2023 | Reyvow, Emgality |
| Arbor Pharmaceuticals, INC. | $12.00 | 2022 | |
| Benco Dental Supply Co. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonia Teruel Castellon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.